Evidence map›Paper›PMID 38925276›Full record

Observational studyF&S science2024

The immune landscape of uterine fibroids as determined by mass cytometry.

Drake Boos, Tsai-Der Chuang, Asghar Abbasi, Anna Luzzi, Omid Khorram

Abstract readObservational Study
In one paragraph

Observational study in F&S science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Drake BoosThe Lundquist Institute for Biomedical Innovation, Torrance, California.
Tsai-Der ChuangThe Lundquist Institute for Biomedical Innovation, Torrance, California.
Asghar AbbasiThe Lundquist Institute for Biomedical Innovation, Torrance, California.
Anna LuzziThe Lundquist Institute for Biomedical Innovation, Torrance, California.
Omid KhorramThe Lundquist Institute for Biomedical Innovation, Torrance, California; Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California, Los Angeles, California. Electronic address: okhorram@lundquist.org.

Funding

Tryptophan metabolism and its role in fibroid pathogenesisR01HD109286 · NICHD · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI OMID A. KHORRAM · 2022 to 2026
$1.9M
Mechanism of Long Non-coding RNAs Action in leiomyomaR01HD100529 · NICHD · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI KHORRAM, OMID A. · 2020 to 2023
$1.7M
NICHD NIH HHS R01 HD100529NICHD NIH HHS R01 HD109286
6 · The paper itself

Abstract

objectiveTo study the differences in immune cell profiles in uterine fibroids (Fibs) and matched myometrium (Myo).

designObservational study.

settingLaboratory study. PATIENT(S): The study included tissue that was collected from 10 pairs of Fib and matched Myo from women, not on hormonal medications, undergoing hysterectomy and myomectomy. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Differences in immune cell and cytokine composition between Fib and matched Myo. RESULT(S): The mass cytometry analysis indicated that Fibs had a significantly higher number of natural killer (NK) cells, total macrophages, M2 macrophages, and conventional dendritic cells when compared with matched Myo from the same patient. In contrast, Fibs had significantly fewer CD3 and CD4 T cells when compared with Myo. The mass cytometry analysis results did not show any significant difference in the number of resting mast cells. Immunoflurorescent and immunohistochemical imaging confirmed the cytometry by time of flight results, showing a significantly higher number of NK cells, tryptase-positive mast cells indicative of mast cell activation, total macrophages, and M2 cells in Fibs and a significantly lower number of CD3 and CD4 T cells. The cytokine assay revealed significantly increased levels of human interferon α2, interleukin (IL)-1α, and platelet-derived growth factor AA and significantly lower levels of macrophage colony-stimulating factor and IL-1 receptor antagonist in Fib. CONCLUSION(S): Our results show significant differences in immune cell populations and cytokine levels between Fib and Myo. These differences could account for the increased inflammation in fib and a potential mechanism by which these tumors evade the immune system. These findings provide a foundation for further studies exploring the role of immune cells in Fib development.

Indexed as

CytokinesLeiomyomaAdultFemaleFlow CytometryHumansKiller Cells, NaturalMacrophagesMast CellsMiddle AgedMyometriumUterine NeoplasmsCytokinesFibroidmacrophagemass cytometryNK cellsT cells

Identifiers

PMID38925276
PMCPMC11404535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.